Died in Health Policy
Summary
The bill would create a new permitting system for outsourcing facilities that compound drugs, obligating them to apply to the Department of Health and submit FDA inspection documentation before operating. The Florida Board of Pharmacy would become the sole state regulator, and FDA inspection reports would count as satisfying any state inspection requirement. Facilities that already held a permit before July 1 2026 could keep operating under that permit until it expires or is otherwise changed.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when SB 966 changes status, plus AI-powered summaries and stage predictions.
Sign up free